Clinical Trial Update: Dabrafenib Alone and in Combination With Trametinib Before Surgery in Treating Patients With Locally or Regionally Advanced Melanoma That Can Be Removed By Surgery [Phase 2]

View source ↗

Summary

Phase 2 study evaluating dabrafenib alone and with trametinib as neoadjuvant therapy before surgery in locally or regionally advanced melanoma; the trial was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dabrafenib (Dabrafenib)
• Trametinib (trametinib)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Recurrent Melanoma, Stage IIB Melanoma (Locally Advanced) | Phase 2 | Status: TERMINATED | Results posted: 2017-06-23